{"id":31516,"date":"2016-03-09T16:09:51","date_gmt":"2016-03-09T16:09:51","guid":{"rendered":"\/fr\/?p=31516"},"modified":"2016-03-09T16:09:51","modified_gmt":"2016-03-09T16:09:51","slug":"consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas","status":"publish","type":"post","link":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/","title":{"rendered":"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS"},"content":{"rendered":"

Sant\u00e9 Canada propose de modifier l\u2019annexe\u00a0III de la Loi r\u00e9glementant certaines drogues et autres substances<\/a> (LRCDAS) en \u00e9largissant la liste du m\u00e9thylph\u00e9nidate et ses sels afin d\u2019y inclure ses d\u00e9riv\u00e9s, ses isom\u00e8res et ses analogues ainsi que leurs sels.<\/p>\n

Les activit\u00e9s avec le m\u00e9thylph\u00e9nidate et ses sels sont autoris\u00e9es en vertu de la Partie\u00a0G de la RAD, lorsqu\u2019elles sont men\u00e9es de fa\u00e7on r\u00e9glement\u00e9e. Toutefois, comme les d\u00e9riv\u00e9s, les isom\u00e8res et les analogues du m\u00e9thylph\u00e9nidate (ainsi que les sels de ceux-ci) ne font l\u2019objet d\u2019aucune utilisation th\u00e9rapeutique approuv\u00e9e, Sant\u00e9 Canada propose de les ajouter \u00e0 la liste de la Partie\u00a0J de la RAD. L\u2019utilisation aux fins scientifiques ou de recherche de ces substances peut \u00eatre autoris\u00e9e en vertu de la Partie\u00a0J de la RAD.<\/p>\n

Sant\u00e9 Canada sollicite vos commentaires au sujet de la proposition. La publication de cet avis<\/a> dans la partie\u00a0I de la Gazette du Canada<\/em> a lanc\u00e9 la p\u00e9riode de commentaires de 30\u00a0jours.
\nLes personnes int\u00e9ress\u00e9es \u00e0 participer \u00e0 ce processus ou ayant des commentaires \u00e0 l\u2019\u00e9gard de cet avis doivent communiquer avec Affaires l\u00e9gislatives et r\u00e9glementaires, Direction des substances contr\u00f4l\u00e9es, Direction g\u00e9n\u00e9rale de la sant\u00e9 environnementale et de la s\u00e9curit\u00e9 des consommateurs, Sant\u00e9 Canada par la poste \u00e0 l\u2019indice de l\u2019adresse suivant\u00a0:\u00a00302A, 150\u00a0Tunney\u2019s Pasture Driveway, Ottawa (Ontario) K1A 0K9, ou par courriel \u00e0 l\u2019adresse ocs_regulatorypolicy-bsc_politiquereglementaire@hc-sc.gc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Sant\u00e9 Canada propose de modifier l\u2019annexe\u00a0III de la Loi r\u00e9glementant certaines drogues et autres substances (LRCDAS) en \u00e9largissant la liste du m\u00e9thylph\u00e9nidate et ses sels afin d\u2019y inclure ses d\u00e9riv\u00e9s, ses isom\u00e8res et ses analogues ainsi que leurs sels. Les activit\u00e9s avec le m\u00e9thylph\u00e9nidate et ses sels sont autoris\u00e9es en vertu de la Partie\u00a0G de… Read more »<\/a><\/p>\n","protected":false},"author":36,"featured_media":31423,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"class_list":["post-31516","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles-de-la-reglementation-canadienne"],"acf":[],"yoast_head":"\nConsultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS - Livingston International<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS - Livingston International\" \/>\n<meta property=\"og:description\" content=\"Sant\u00e9 Canada propose de modifier l\u2019annexe\u00a0III de la Loi r\u00e9glementant certaines drogues et autres substances (LRCDAS) en \u00e9largissant la liste du m\u00e9thylph\u00e9nidate et ses sels afin d\u2019y inclure ses d\u00e9riv\u00e9s, ses isom\u00e8res et ses analogues ainsi que leurs sels. Les activit\u00e9s avec le m\u00e9thylph\u00e9nidate et ses sels sont autoris\u00e9es en vertu de la Partie\u00a0G de... Read more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/\" \/>\n<meta property=\"og:site_name\" content=\"Livingston International\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/livingstoninternational\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-09T16:09:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"240\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dan Ovsey\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dan Ovsey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/\"},\"author\":{\"name\":\"Dan Ovsey\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37\"},\"headline\":\"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS\",\"datePublished\":\"2016-03-09T16:09:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg\",\"articleSection\":[\"Nouvelles de la r\u00e9glementation canadienne\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/\",\"url\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/\",\"name\":\"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS - Livingston International\",\"isPartOf\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg\",\"datePublished\":\"2016-03-09T16:09:51+00:00\",\"author\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage\",\"url\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg\",\"contentUrl\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg\",\"width\":240,\"height\":160,\"caption\":\"Sant\u00e9 Canada propose de modifier l\u2019annexe III de la Loi r\u00e9glementant certaines drogues et autres substances (LRCDAS) en \u00e9largissant la liste du m\u00e9thylph\u00e9nidate et ses sels afin d\u2019y inclure ses d\u00e9riv\u00e9s, ses isom\u00e8res et ses analogues ainsi que leurs sels.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/staging.livingstonintl.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#website\",\"url\":\"https:\/\/staging.livingstonintl.com\/fr\/\",\"name\":\"Livingston International\",\"description\":\"Simplify Trade\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.livingstonintl.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37\",\"name\":\"Dan Ovsey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g\",\"caption\":\"Dan Ovsey\"},\"url\":\"https:\/\/staging.livingstonintl.com\/fr\/author\/dan-ovsey\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS - Livingston International","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS - Livingston International","og_description":"Sant\u00e9 Canada propose de modifier l\u2019annexe\u00a0III de la Loi r\u00e9glementant certaines drogues et autres substances (LRCDAS) en \u00e9largissant la liste du m\u00e9thylph\u00e9nidate et ses sels afin d\u2019y inclure ses d\u00e9riv\u00e9s, ses isom\u00e8res et ses analogues ainsi que leurs sels. Les activit\u00e9s avec le m\u00e9thylph\u00e9nidate et ses sels sont autoris\u00e9es en vertu de la Partie\u00a0G de... Read more »","og_url":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/","og_site_name":"Livingston International","article_publisher":"https:\/\/www.facebook.com\/livingstoninternational","article_published_time":"2016-03-09T16:09:51+00:00","og_image":[{"width":240,"height":160,"url":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg","type":"image\/jpeg"}],"author":"Dan Ovsey","twitter_misc":{"\u00c9crit par":"Dan Ovsey","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#article","isPartOf":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/"},"author":{"name":"Dan Ovsey","@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37"},"headline":"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS","datePublished":"2016-03-09T16:09:51+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/"},"wordCount":288,"image":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage"},"thumbnailUrl":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg","articleSection":["Nouvelles de la r\u00e9glementation canadienne"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/","url":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/","name":"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS - Livingston International","isPartOf":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage"},"image":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage"},"thumbnailUrl":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg","datePublished":"2016-03-09T16:09:51+00:00","author":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37"},"breadcrumb":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#primaryimage","url":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg","contentUrl":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2016\/03\/25230305\/Untitled-1-1.jpg","width":240,"height":160,"caption":"Sant\u00e9 Canada propose de modifier l\u2019annexe III de la Loi r\u00e9glementant certaines drogues et autres substances (LRCDAS) en \u00e9largissant la liste du m\u00e9thylph\u00e9nidate et ses sels afin d\u2019y inclure ses d\u00e9riv\u00e9s, ses isom\u00e8res et ses analogues ainsi que leurs sels."},{"@type":"BreadcrumbList","@id":"https:\/\/staging.livingstonintl.com\/fr\/consultation-de-sante-canada-sur-la-modification-proposee-visant-a-ajouter-des-substances-a-la-liste-du-methylphenidate-de-la-lrcdas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/staging.livingstonintl.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Consultation de Sant\u00e9 Canada sur la modification propos\u00e9e visant \u00e0 ajouter des substances \u00e0 la liste du m\u00e9thylph\u00e9nidate de la LRCDAS"}]},{"@type":"WebSite","@id":"https:\/\/staging.livingstonintl.com\/fr\/#website","url":"https:\/\/staging.livingstonintl.com\/fr\/","name":"Livingston International","description":"Simplify Trade","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.livingstonintl.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37","name":"Dan Ovsey","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g","caption":"Dan Ovsey"},"url":"https:\/\/staging.livingstonintl.com\/fr\/author\/dan-ovsey\/"}]}},"_links":{"self":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/posts\/31516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/comments?post=31516"}],"version-history":[{"count":0,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/posts\/31516\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/media\/31423"}],"wp:attachment":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/media?parent=31516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/categories?post=31516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}